YIDU TECH

Yidu Tech's share price fell today, primarily due to profit-taking and market skepticism about the monetization of its AI healthcare business. The stock experienced a rally-to-retreat pattern, hitting an intraday high of HKD 4.66 in the morning session before sliding to close at HKD 4.43, a decline of about 5.3%, and nearing its 52-week low of HKD 4.05. Despite posting a FY2026 net profit of HKD 78.77 million—its first full-year profit—and declaring a final dividend of HKD 0.04 per share, the stock trades below its 20-day MA (HKD 4.955) and 60-day MA (HKD 5.286), with a YTD decline of 17.2%. However, recent contract wins, including a RMB 7.39 million AI clinical research platform bid in Tianjin, suggest ongoing business momentum.

Yidu Tech dropped sharply today, moving in a single downward direction throughout the session, closing 5.94% lower at HKD 4.92. The stock now sits 32.2% below its 52-week high of HKD 7.24 and has fallen below its 20-day moving average of HKD 4.962. The decline was driven by profit-taking after the company's FY2026 full-year results, which showed its first-ever annual profit (net profit of RMB 78.78 million, revenue up 14.6% to RMB 819.3 million) and a proposed final dividend of HKD 0.04 per share. However, the stock set an intraday low of HKD 4.88, while a win of a RMB 7.39 million AI clinical research platform project in Tianjin provided some offset.

Yidu Tech surged in the morning session, closing at HK$5.500 at midday, up 4.96%, with an intraday range of HK$5.170 to HK$5.520. The rally was driven by its first full-year profit in FY2026, posting a net profit of RMB 78.8 million on revenue growth of 14.6% to RMB 819.3 million, alongside a proposed final dividend of HK$0.04 per share. Net profit growth exceeded 220% in the past two quarters, while operating margin improved to 18.93%. However, the stock remains 24.03% below its 52-week high of HK$7.24 and trades near the 60-day MA of HK$5.482, with a YTD gain of only 2.8%, indicating lingering caution on the sustainability of AI healthcare monetization.

医渡科技今日收涨 6.16% 至 5.17 港元，主因公司刚公布 FY2026 全年首次实现盈利，净利润达 7877 万港元，并宣派每股 0.04 港元末期股息，消息推动股价低开高走，上午盘从 4.99 港元一路攀升至 5.22 港元，下午盘进一步冲高至 5.30 港元日内高点后小幅回落，但仍守住 5.17 港元收盘。财报显示 Q4 营收同比增长 26.64% 至 2.61 亿港元，营业利润大增 223.18%，盈利能力显著改善，但当前股价仍低于 52 周高点 7.24 港元约 28.6%，且年初至今下跌 3.36%，低于 60 日均线 5.49 港元，反映市场对盈利可持续性仍有疑虑。不过，公司市值约 52.73 亿港元，市净率 1.28 倍，市盈率 64 倍，估值处于历史低位区间。